Foundation Asset Management, LP - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 89 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.

Quarter-by-quarter ownership
Foundation Asset Management, LP ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2018$616,000
-93.6%
27,154
-93.2%
0.53%
-85.2%
Q1 2018$9,689,000
-19.7%
399,537
-7.6%
3.59%
-1.1%
Q4 2017$12,063,000
-18.5%
432,5320.0%3.63%
-21.4%
Q3 2017$14,810,000
-17.6%
432,532
-4.2%
4.62%
-22.9%
Q2 2017$17,980,000
+8.2%
451,3060.0%5.99%
+3.7%
Q1 2017$16,617,000
+2.4%
451,306
-11.3%
5.77%
+17.0%
Q4 2016$16,230,000
+5.7%
509,083
+20.1%
4.93%
-5.1%
Q3 2016$15,361,000
+33.0%
423,881
-16.7%
5.20%
+35.3%
Q2 2016$11,547,000
+20.7%
508,8810.0%3.84%
+40.1%
Q1 2016$9,567,000
+14.7%
508,8810.0%2.74%
+0.1%
Q4 2015$8,341,000
+30.0%
508,881
-12.8%
2.74%
+52.2%
Q3 2015$6,417,000
-15.6%
583,8810.0%1.80%
-14.6%
Q2 2015$7,602,000
-25.0%
583,8810.0%2.11%
-18.6%
Q1 2015$10,130,000
-27.3%
583,881
-37.5%
2.59%
-22.3%
Q4 2014$13,934,000
-29.3%
933,881
+9.1%
3.34%
-38.3%
Q3 2014$19,722,000
+34.7%
855,616
+86.3%
5.41%
+28.7%
Q2 2014$14,640,000459,2344.20%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders